OTC · Medical - Devices

Polarean Imaging plc (PLLWF) Stock

$0.01 +0.00% OTC: PLLWF Healthcare

Polarean Imaging plc operates as a specialized entity within the medical imaging sector, focusing on integrated drug-device solutions. The company extends its services across international markets, including the United States, Canada, Germany, and the United Kingdom.

Valuation

MetricValue
Price$0.01
Market Cap$7.97M
P/E Ratio-0.12
P/B Ratio0.07
P/S Ratio0.54
EPS (TTM)$-0.01
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-65.39%
ROA-42.32%
ROCE-53.94%
Gross Margin14.83%
Operating Margin-283.15%
Net Margin-276.38%
Debt/Equity0.04
Current Ratio4.64

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.0M$1.0M$1.0M$1.0M$3.0M
Operating Profit$-7.0M$-14.0M$-14.0M$-13.0M$-9.0M
Net Profit$-7.0M$-14.0M$-14.0M$-12.0M$-9.0M
EPS$-0.04$-0.07$-0.07$-0.06$-0.01
Op Margin-626.0%-1207.7%-1323.4%-1409.3%-283.1%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$11.0M$35.0M$23.0M$11.0M$16.0M
Total Liabilities$2.0M$3.0M$3.0M$3.0M$4.0M
Cash$6.0M$29.0M$16.0M$6.0M$12.0M
Borrowings$0$0$1.0M$0$1.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-6.0M$-12.0M$-12.0M$-10.0M$-6.0M
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$-2.0M$0$0$-1.0M
Net Cash Flow$4.0M$23.0M$-12.0M$-10.0M$6.0M
Free Cash Flow$-6.0M$-13.0M$-12.0M$-11.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA1.74
FCF Yield-332.27%
Quick Ratio4.18
Interest Coverage-540.85
Return 1Y-40.00%
Return 3Y-97.25%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Polarean Imaging plc

Polarean Imaging plc operates as a specialized entity within the medical imaging sector, focusing on integrated drug-device solutions. The company extends its services across international markets, including the United States, Canada, Germany, and the United Kingdom. At its core, Polarean is engaged in the creation and market introduction of advanced gas polarizer systems and associated ancillary instruments. A significant aspect of their innovation lies in developing specialized equipment that enhances conventional magnetic resonance imaging (MRI) machines, enabling them to perform advanced functional pulmonary imaging. The company distinguishes itself by specializing in the application of hyperpolarized xenon gas (129Xe) as a unique imaging agent. This technology allows for the detailed visualization of regional ventilation and gas exchange within the lungs, particularly in the smallest airways, the interface between the lung tissue and the bloodstream, and the pulmonary vasculature, thereby offering a novel diagnostic method. Furthermore, Polarean Imaging plc is actively involved in the design and manufacturing of the specific MRI radiofrequency coils that are indispensable for imaging 129Xe within an MRI system. Established in 2016, the company's base of operations is located in Durham, North Carolina.

Polarean Imaging plc is headquartered in GB.

Polarean Imaging plc (PLLWF) stock trades at $0.01 with a market capitalization of $7.97M. The stock is valued at a price-to-earnings (P/E) ratio of -0.12, price-to-book of 0.07, price-to-sales of 0.54. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.

On profitability, Polarean Imaging plc generates a return on equity (ROE) of -65.39%, return on capital employed of -53.94%, an operating margin of -283.15%, a net profit margin of -276.38%.

Official website: polarean.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides